ReviewThe British journal of radiology2026
Nuclear medicine in the operating room: present and future.
Review in The British journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current role of nuclear medicine in the operating room is closely related to the enhancement of the sentinel node (SN) procedure developed more than 3 decades ago. At that moment, the so-called triple approach (lymphoscintigraphy, gamma probe detection, and blue dye) was established as the standard of care for SN biopsy in melanoma and breast cancer. It also marked a first international multidisciplinary learning effort based on skill transfer and outcome evaluation, laying the fundaments to delineate the emerging field of interventional nuclear medicine (iNM) thanks to a similar multimodality approach and multidisciplinary practice. Currently, imaging modalities like SPECT/CT and PET/CT allow to preoperatively generate precision roadmaps for navigation in the operating room. The combination of modern technologies has facilitated iNM incorporation for surgery in more complex anatomical areas. The SN procedure has been expanded to different gynecological and urological malignancies as well as head and neck and gastrointestinal cancers. Besides iNM for open surgery, it is also possible to guide robot-assisted laparoscopic procedures for both SN biopsy and resection of oligometastases. The increasing development of hybrid tracers for combined radioguidance and fluorescence will reinforce the role of iNM in the future. The aim of this review is to comprehensively evaluate the contribution of nuclear medicine concerning current clinical applications and technological advances in the field of radioguided surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.